Trident Lifeline Limited Share Price
Trident Lifeline Limited Share Price Today
As of 5 Jul 2026, Trident Lifeline Limited share price is ₹265.25. The stock opened at ₹269.00, compared to its previous close of ₹261.60. During today's trading session, Trident Lifeline Limited share price moved in the range of ₹262.10 to ₹269.00, with an average price of ₹265.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹229.95 and a high of ₹328.00.
Trident Lifeline Limited Returns Calculator
Trident Lifeline Limited Shareholder Returns
Trident Lifeline Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Trident Lifeline Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹86.96 | ₹44.63 | ₹31.69 | ₹21.77 |
| Other Income | ₹8.23 | ₹2.08 | ₹1.16 | ₹0.60 |
| Total Revenue | ₹95.20 | ₹46.71 | ₹32.85 | ₹22.37 |
| Total Expenses | ₹81.58 | ₹38.01 | ₹26.27 | ₹19.39 |
| Profit Before Tax | ₹13.61 | ₹8.70 | ₹6.58 | ₹2.98 |
| Tax | ₹3.12 | ₹2.76 | ₹0.56 | -₹0.96 |
| Profit After Tax | ₹10.49 | ₹5.94 | ₹6.02 | ₹3.95 |
| EPS - Basic | ₹10.22 | ₹5.52 | ₹6.22 | ₹6.92 |
| EPS - Diluted | ₹10.22 | ₹5.52 | ₹6.22 | ₹6.92 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹13.61 | ₹8.70 | ₹6.58 | ₹2.98 |
| Income before WC changes | ₹20.47 | ₹8.81 | ₹6.66 | ₹3.31 |
| Change in Assets | -₹27.26 | -₹9.86 | -₹25.73 | -₹2.91 |
| Change in Liabilities | ₹2.44 | ₹6.92 | ₹1.21 | -₹0.82 |
| Change in WC | -₹24.82 | -₹2.94 | -₹24.52 | -₹3.72 |
| Cash flow from Operations | -₹10.24 | ₹2.23 | -₹19.00 | -₹0.21 |
| Cash flow from Investing | -₹13.82 | -₹20.36 | -₹9.69 | -₹0.45 |
| Cash flow from Financing | ₹19.76 | ₹11.01 | ₹42.28 | ₹0.80 |
| Total Cash Flow | -₹4.31 | -₹7.13 | ₹13.60 | ₹0.14 |
| Cash (Start of the year) | ₹6.65 | ₹13.78 | ₹0.18 | ₹0.01 |
| Cash (End of the year) | ₹2.46 | ₹6.65 | ₹13.78 | ₹0.16 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹65.63 | ₹35.10 | ₹13.36 | ₹3.17 |
| Current Assets | ₹90.37 | ₹51.97 | ₹49.21 | ₹10.67 |
| Total Assets | ₹156.01 | ₹87.08 | ₹62.57 | ₹13.83 |
| Current Liabilities | ₹53.55 | ₹20.26 | ₹11.53 | ₹7.57 |
| Net Current Asset | ₹36.82 | ₹31.72 | ₹37.68 | ₹3.10 |
| Non-Current Liabilities | ₹32.80 | ₹12.87 | ₹3.93 | ₹1.49 |
| Equity Capital | ₹69.65 | ₹53.95 | ₹47.11 | ₹4.78 |
| Total Equity & Liabilities | ₹156.01 | ₹87.08 | ₹62.57 | ₹13.83 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹67.80 | ₹44.65 | ₹31.69 | ₹21.77 |
| Other Income | ₹3.14 | ₹2.20 | ₹1.15 | ₹0.60 |
| Total Revenue | ₹70.94 | ₹46.86 | ₹32.85 | ₹22.37 |
| Total Expenses | ₹53.03 | ₹37.06 | ₹26.27 | ₹19.39 |
| Profit Before Tax | ₹17.91 | ₹9.80 | ₹6.57 | ₹2.98 |
| Tax | ₹4.85 | ₹2.76 | ₹0.56 | -₹0.96 |
| Profit After Tax | ₹13.05 | ₹7.04 | ₹6.01 | ₹3.95 |
| EPS - Basic | ₹11.35 | ₹6.13 | ₹6.22 | ₹6.92 |
| EPS - Diluted | ₹11.35 | ₹6.13 | ₹6.22 | ₹6.92 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹17.91 | ₹9.80 | ₹6.57 | ₹2.98 |
| Income before WC changes | ₹18.46 | ₹9.27 | ₹6.66 | ₹3.31 |
| Change in Assets | -₹20.06 | -₹12.88 | -₹23.58 | -₹2.91 |
| Change in Liabilities | ₹2.34 | ₹6.88 | ₹0.89 | -₹0.83 |
| Change in WC | -₹17.71 | -₹6.00 | -₹22.69 | -₹3.73 |
| Cash flow from Operations | -₹3.49 | ₹0.90 | -₹16.60 | -₹0.19 |
| Cash flow from Investing | -₹7.88 | -₹11.01 | -₹5.56 | -₹0.50 |
| Cash flow from Financing | ₹7.47 | ₹2.35 | ₹35.80 | ₹0.80 |
| Total Cash Flow | -₹3.90 | -₹7.76 | ₹13.64 | ₹0.11 |
| Cash (Start of the year) | ₹6.01 | ₹13.77 | ₹0.13 | ₹0.01 |
| Cash (End of the year) | ₹2.11 | ₹6.01 | ₹13.77 | ₹0.13 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹28.65 | ₹20.26 | ₹8.64 | ₹3.19 |
| Current Assets | ₹69.14 | ₹52.98 | ₹47.86 | ₹10.64 |
| Total Assets | ₹97.79 | ₹73.24 | ₹56.50 | ₹13.82 |
| Current Liabilities | ₹25.14 | ₹16.91 | ₹10.34 | ₹7.56 |
| Net Current Asset | ₹44.00 | ₹36.07 | ₹37.52 | ₹3.08 |
| Non-Current Liabilities | ₹6.93 | ₹3.65 | ₹0.53 | ₹1.49 |
| Equity Capital | ₹65.73 | ₹52.68 | ₹45.63 | ₹4.78 |
| Total Equity & Liabilities | ₹97.79 | ₹73.24 | ₹56.50 | ₹13.82 |
About Trident Lifeline Limited
Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a loan license and a contract manufacturing model. It deals in capsules, tablets, liquid ointments, gels, ice gels, mouthwash, paste, solution, suspension, toothpaste, syrup, and cream. The product portfolio of the Company comprises a wide range of drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Cure, Pr, Multivitamin, Multimineral Nyteraceutoton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti-Lipidemic Drug, Anti-Parasiticical and Non-steroidal anti-inflammatory drugs (NSAIDS).
Trident Lifeline Limited Financial Highlights
- Revenue: Trident Lifeline Limited reported revenue of ₹138.29 crore in FY26 vs ₹95.19 crore in FY25. It showed an increase of 45.28% on a yearly basis.
- Operating Profit: Trident Lifeline Limited reported an operating profit of ₹27.19 crore in FY26 vs ₹13.61 crore in FY25. It showed an increase of 99.78% on a year-on-year basis.
- Net Profit: Trident Lifeline Limited reported a net profit of ₹19.32 crore in FY26 vs ₹10.49 crore in FY25. It showed an increase of 84.18% on a yearly basis.
Trident Lifeline Limited Quarterly Result Highlights
- Trident Lifeline Limited reported revenue of ₹30.34 crore in Dec 2025, compared with ₹33.01 crore in Sep 2025, representing a decrease of 8.09% on a quarter-on-quarter (QoQ) basis.
- Trident Lifeline Limited reported an operating profit of ₹6.02 crore in Dec 2025, compared with ₹6.63 crore in Sep 2025, representing a decrease of 9.20% on a quarter-on-quarter (QoQ) basis.
- Trident Lifeline Limited reported a profit of ₹4.65 crore in Dec 2025, compared with ₹5.09 crore in Sep 2025, reflecting a decrease of 8.64% on a QoQ basis.
- The earnings per share (EPS) of Trident Lifeline Limited stood at ₹10.22 during Dec 2025.
Similar Stocks
FAQs on Trident Lifeline Limited Share Price
What is Trident Lifeline Limited share price today?
Trident Lifeline Limited share price is ₹265.25 as on 03 Jul, 2026, 15:40 IST.
How has the Trident Lifeline Limited share price performed in the past?
In the last 1 year, Trident Lifeline Limited delivered a return of -1.76%. The Trident Lifeline Limited share price hit a high of ₹328.00 and low of ₹229.95.
How much is the Mutual Fund shareholding in Trident Lifeline Limited shares?
The Mutual Fund Shareholding in Trident Lifeline Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Trident Lifeline Limited shares ?
The 52-week high and low of Trident Lifeline Limited share is ₹328.00 and ₹229.95 as of 03 Jul, 2026.
What is the market cap of Trident Lifeline Limited?
The market capitalisation of Trident Lifeline Limited is ₹312.17 Crores as on 03 Jul, 2026.
What are the stock symbols of Trident Lifeline Limited?
The stock symbol of Trident Lifeline Limited is 543616 on the BSE, and the ISIN is INE0MKA01014.
What was yesterday's closing price for Trident Lifeline Limited shares ?
Trident Lifeline Limited shares closed yesterday at ₹261.60 on BSE
How to buy Trident Lifeline Limited shares?
To buy Trident Lifeline Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Trident Lifeline Limited shares on Holidays?
No, shares of Trident Lifeline Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Trident Lifeline Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Trident Lifeline Limited?
The PE and PB ratio of Trident Lifeline Limited is 16.16 and 3.11 respectively, as on 03 Jul, 2026, 15:40 IST.